| Nome |
# |
|
Is there long-term value of pathology scoring in immunoglobulin
A nephropathy? A validation study of the Oxford
Classification for IgA Nephropathy (VALIGA) update, file e2f56ed8-a0ef-3eaf-e053-3a05fe0a5d97
|
629
|
|
Standardized reporting of monoclonal iImmunoglobulin-associated renal diseases: Recommendations from a Mayo Clinic/Renal Pathology Society Working Group, file e2f56ed9-ad9e-3eaf-e053-3a05fe0a5d97
|
577
|
|
Treatment of primary membranous nephropathy: where are we now?, file e2f56ed8-9606-3eaf-e053-3a05fe0a5d97
|
565
|
|
Overexpression of the cytokine BAFF and autoimmunity risk, file e2f56ed6-7b51-3eaf-e053-3a05fe0a5d97
|
298
|
|
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry, file e2f56eda-c454-3eaf-e053-3a05fe0a5d97
|
177
|
|
KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation, file e2f56ed6-a2b9-3eaf-e053-3a05fe0a5d97
|
153
|
|
Immunosuppressive treatment in dialysis patients, file e2f56ed8-c96a-3eaf-e053-3a05fe0a5d97
|
152
|
|
Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up, file e2f56ed8-ac59-3eaf-e053-3a05fe0a5d97
|
149
|
|
Unexpected Outcomes of Renal Function after Radical Nephrectomy: Histology Relevance along with Clinical Aspects, file e2f56eda-d448-3eaf-e053-3a05fe0a5d97
|
123
|
|
Exercise-Associated hyponatremia: 2017 update, file e2f56ed8-d216-3eaf-e053-3a05fe0a5d97
|
122
|
|
Kidney size in relation to ageing, gender, renal function, birthweight and chronic kidney disease risk factors in a general population, file e2f56ed8-8259-3eaf-e053-3a05fe0a5d97
|
118
|
|
Renal function during long-term lithium treatment: a cross-sectional and longitudinal study, file e2f56ed3-b4cf-3eaf-e053-3a05fe0a5d97
|
117
|
|
Pregnancy outcomes after kidney graft in Italy: are the changes over time the result of different therapies or of different policies? A nationwide survey (1978-2013), file e2f56ed8-2c72-3eaf-e053-3a05fe0a5d97
|
116
|
|
Efficiency and nutritional parameters in an elderly high risk population on hemodialysis and hemodiafiltration in Italy and France: different treatments with similar names?, file e2f56ed8-c919-3eaf-e053-3a05fe0a5d97
|
112
|
|
The children of dialysis: live-born babies from on-dialysis mothers in Italy--an epidemiological perspective comparing dialysis, kidney transplantation and the overall population, file e2f56ed8-26c9-3eaf-e053-3a05fe0a5d97
|
110
|
|
Circulating antithyroid antibodies contribute to the decrease of glomerular filtration rate in lithium-treated patients: a longitudinal study, file e2f56ed7-4067-3eaf-e053-3a05fe0a5d97
|
108
|
|
Corticosteroid treatment influences TA-Proteinuria and renal survival in IgA nephropathy, file e2f56ed8-26ca-3eaf-e053-3a05fe0a5d97
|
96
|
|
Compliance, illiteracy and low-protein diet: multiple challenges in CKD and a case of self-empowerment, file e2f56ed8-26b9-3eaf-e053-3a05fe0a5d97
|
94
|
|
Vegan-vegetarian low-protein supplemented diets in pregnant CKD patients: fifteen years of experience, file e2f56ed8-2c76-3eaf-e053-3a05fe0a5d97
|
94
|
|
History of Preeclampsia in Patients Undergoing a Kidney Biopsy: A Biphasic, Multiple-Hit Pathogenic Hypothesis, file e2f56eda-6991-3eaf-e053-3a05fe0a5d97
|
61
|
|
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis, file e2f56ed9-7db2-3eaf-e053-3a05fe0a5d97
|
51
|
|
How Genetics Can Improve Clinical Practice in Chronic Kidney Disease: From Bench to Bedside, file e2f56eda-8cd9-3eaf-e053-3a05fe0a5d97
|
44
|
|
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments, file e2f56ed8-26c2-3eaf-e053-3a05fe0a5d97
|
43
|
|
COVID-19 Vaccine Hesitancy in Patients on Dialysis in Italy and France, file e2f56eda-5574-3eaf-e053-3a05fe0a5d97
|
40
|
|
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey, file e2f56eda-c981-3eaf-e053-3a05fe0a5d97
|
39
|
|
Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: Protocol of a pilot randomised controlled trial, file e2f56ed9-6f4d-3eaf-e053-3a05fe0a5d97
|
22
|
|
Chronic kidney disease of undetermined etiology around the world, file e2f56eda-4cc4-3eaf-e053-3a05fe0a5d97
|
20
|
|
The impact of the secondary infections in ICU patients affected by COVID-19 during three different phases of the SARS-CoV-2 pandemic, file 4d688703-d1dd-432d-abf4-51349392d786
|
19
|
|
Renal function at follow-up in a cohort of patients who had shown reduced glomerular filtration rate during long-term treatment with lithium, file 9b9322f7-c644-4191-90ec-02f54e875d69
|
17
|
|
Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients, file e2f56eda-d988-3eaf-e053-3a05fe0a5d97
|
15
|
|
Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients, file f6e0c8ef-cc97-4c28-82b0-84e1580502c8
|
12
|
|
Extensive proximal tubular necrosis without recovery following the ingestion of Amanita phalloides: a case report, file e2f56eda-9593-3eaf-e053-3a05fe0a5d97
|
11
|
|
Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: Insights from the START study, file 2d158930-6f95-46f2-ae5c-2d5332f9cebd
|
9
|
|
Classification and Management of MGRS Related Diseases, file c3fcb344-8c74-4dbc-9c33-b03a15742afd
|
8
|
|
Risk of adverse pregnancy outcomes in women with CKD, file e2f56ed8-2c77-3eaf-e053-3a05fe0a5d97
|
8
|
|
Transplant Candidate with Cancer: Should We Proceed?, file 32165240-f5f7-424d-a80a-908919e51869
|
7
|
|
Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario, file 811dcf38-c2cc-4ed8-8f71-7e6daa1ff76f
|
7
|
|
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification, file 1381f326-ab21-4a43-aba3-57f067773506
|
5
|
|
Parathyroidectomy and survival in a cohort of Italian dialysis patients: results of a multicenter, observational, prospective study, file a9ffa195-7d01-44e4-84ce-d379613f7bcc
|
5
|
|
Una svolta nella terapia dialitica sostitutiva? | [A breakthrough in renal replacement therapy?], file e2f56ed8-2c71-3eaf-e053-3a05fe0a5d97
|
5
|
|
Radiopacity of Sodium Zirconium Cyclosilicate in Computed Tomography: a case of a patient with Hyperkalemia and kidney disease, file 8bdbbf14-c584-4929-809a-4ba0112875af
|
4
|
|
Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes, file e2f56ed8-2c78-3eaf-e053-3a05fe0a5d97
|
4
|
|
Long-term lithium and estimated glomerular filtration rate, file e2f56ed8-415b-3eaf-e053-3a05fe0a5d97
|
4
|
|
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine, file e2f56ed8-9993-3eaf-e053-3a05fe0a5d97
|
4
|
|
Outcomes of Pregnancies after Kidney Transplantation: Lessons Learned from CKD. A Comparison of Transplanted, Nontransplanted Chronic Kidney Disease Patients and Low-Risk Pregnancies: A Multicenter Nationwide Analysis, file e2f56ed9-7053-3eaf-e053-3a05fe0a5d97
|
4
|
|
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy, file 599425cf-d803-4451-adbf-93d3632fb3a7
|
3
|
|
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease, file 7d28c7ce-6f0e-4e6a-bb79-871f07faf679
|
3
|
|
An Integrated Multidisciplinary Approach to the Care of Renal Cancer Patients Undergoing Nephrectomy, file 9ad3f0b1-d043-4876-9d50-4f2f8db05d39
|
3
|
|
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens, file e2f56ed8-26ba-3eaf-e053-3a05fe0a5d97
|
3
|
|
Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question), file e2f56ed8-26be-3eaf-e053-3a05fe0a5d97
|
3
|
|
Prevalence of CKD and its relationship to eGFR-related genetic loci and clinical risk factors in the SardiNIA study cohort, file e2f56ed8-26c5-3eaf-e053-3a05fe0a5d97
|
3
|
|
Risk for chronic kidney disease in the general population Italian reports for World Kidney Days 2007-2009, file e2f56ed8-26c7-3eaf-e053-3a05fe0a5d97
|
3
|
|
Multi-center study on HCV-related cryoglobulinemic glomerulonephritis: treatment, file e2f56ed8-7d07-3eaf-e053-3a05fe0a5d97
|
3
|
|
Linee guida alla prevenzione, diagnosi e terapia delle sindromi di danno renale acuto: versione italiana delle KDIGO, integrata con le nuove evidenze e i commentari internazionali = Guidelines for the prevention, diagnosis and treatment of acute kidney injury syndromes: Italian version of KDIGO, integrated with new evidence and international commentaries, file e2f56eda-57bd-3eaf-e053-3a05fe0a5d97
|
3
|
|
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy, file bee44725-760e-405c-bf8f-434ac58c08ee
|
2
|
|
Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes, file e2f56ed3-b5c4-3eaf-e053-3a05fe0a5d97
|
2
|
|
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome, file e2f56ed8-24b9-3eaf-e053-3a05fe0a5d97
|
2
|
|
IgA nephropathy with severe chronic renal failure: A randomized controlled trial of corticosteroids and azathioprine, file e2f56ed8-26bb-3eaf-e053-3a05fe0a5d97
|
2
|
|
Patient Selection and Timing of Continuous Renal Replacement Therapy, file e2f56ed8-26bd-3eaf-e053-3a05fe0a5d97
|
2
|
|
Diabetic kidney disease: A syndrome rather than a single disease, file e2f56ed8-26bf-3eaf-e053-3a05fe0a5d97
|
2
|
|
Approach to Diagnosis and Treatment of Hypercalcemia in a Patient With Malignancy, file e2f56ed8-26c0-3eaf-e053-3a05fe0a5d97
|
2
|
|
Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy, file e2f56ed8-26c6-3eaf-e053-3a05fe0a5d97
|
2
|
|
Diagnosis of complement alternative pathway disorders, file e2f56ed8-2c6d-3eaf-e053-3a05fe0a5d97
|
2
|
|
Pregnancy in Chronic Kidney Disease: questions and answers in a changing panorama, file e2f56ed8-2c6f-3eaf-e053-3a05fe0a5d97
|
2
|
|
Sodium and Volume Disorders in Advanced Chronic Kidney Disease, file e2f56ed8-2c70-3eaf-e053-3a05fe0a5d97
|
2
|
|
A multicenter study of the predictive value of crescents in IgA nephropathy, file e2f56ed8-6977-3eaf-e053-3a05fe0a5d97
|
2
|
|
Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. The Italian Group of Renal Immunopathology, file e2f56ed8-7d03-3eaf-e053-3a05fe0a5d97
|
2
|
|
Acute renal failure after massive ingestion of gliclazide in a suicide attempt, file e2f56ed8-a9ee-3eaf-e053-3a05fe0a5d97
|
2
|
|
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes, file e2f56ed9-ac58-3eaf-e053-3a05fe0a5d97
|
2
|
|
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy, file e2f56eda-a170-3eaf-e053-3a05fe0a5d97
|
2
|
|
Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy, file e2f56eda-c308-3eaf-e053-3a05fe0a5d97
|
2
|
|
Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up, file 095e25f4-e0c1-4cca-8868-6f6fa0971860
|
1
|
|
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12, file e2f56ed7-857b-3eaf-e053-3a05fe0a5d97
|
1
|
|
CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations, file e2f56ed8-24ba-3eaf-e053-3a05fe0a5d97
|
1
|
|
Glomerular diseases and cancer: evaluation of underlying malignancy, file e2f56ed8-26c3-3eaf-e053-3a05fe0a5d97
|
1
|
|
Prevalence of hypertension in a large cohort of Italian hemodialysis patients: results of a cross-sectional study, file e2f56ed8-2c6e-3eaf-e053-3a05fe0a5d97
|
1
|
|
FSGS: from pathogenesis to the histological lesion, file e2f56ed8-2c73-3eaf-e053-3a05fe0a5d97
|
1
|
|
Una nuova terapia per l'amiloidosi renale di tipo AA...e non solo? | [A new treatment of renal disease in AA amyloidosis...and not only that?], file e2f56ed8-2c75-3eaf-e053-3a05fe0a5d97
|
1
|
|
Changes in proteinuria and side effects of corticosteroids alone or in combination with azathioprine at different stages of IgA nephropathy, file e2f56ed8-2c79-3eaf-e053-3a05fe0a5d97
|
1
|
|
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group, file e2f56ed8-8260-3eaf-e053-3a05fe0a5d97
|
1
|
|
Opening an onconephrology clinic: recommendations and basic requirements, file e2f56ed8-95fd-3eaf-e053-3a05fe0a5d97
|
1
|
|
Diagnostic significance and antigen specificity of antineutrophil cytoplasmic antibodies in renal diseases: A prospective multicentre study, file e2f56ed8-9814-3eaf-e053-3a05fe0a5d97
|
1
|
|
Genome-Wide Analysis Studies and Chronic Kidney Disease, file e2f56ed8-b67c-3eaf-e053-3a05fe0a5d97
|
1
|
|
Multicenter study on parathyroidectomy (PTX) in Italy: preliminary results, file e2f56ed8-c57a-3eaf-e053-3a05fe0a5d97
|
1
|
|
Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy, file e2f56ed9-986e-3eaf-e053-3a05fe0a5d97
|
1
|
|
Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study, file e2f56ed9-ac5a-3eaf-e053-3a05fe0a5d97
|
1
|
|
PRF1 mutation alters immune system activation, inflammation, and risk of autoimmunity, file e2f56eda-5dd3-3eaf-e053-3a05fe0a5d97
|
1
|
|
Tossicità renale da farmaci antineoplastici, file e2f56eda-95ff-3eaf-e053-3a05fe0a5d97
|
1
|
|
Ramipril and cardiovascular outcomes in patients on maintenance hemodialysis. The ARCADIA multicenter randomized controlled trial, file e2f56eda-aceb-3eaf-e053-3a05fe0a5d97
|
1
|
|
Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD, file e2f56eda-ba77-3eaf-e053-3a05fe0a5d97
|
1
|
|
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool, file e2f56eda-c3ad-3eaf-e053-3a05fe0a5d97
|
1
|
|
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial, file e2f56eda-cbdd-3eaf-e053-3a05fe0a5d97
|
1
|
|
Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: Evidence from the VALidation of IGA study cohort, file e2f56eda-d98a-3eaf-e053-3a05fe0a5d97
|
1
|
|
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study, file e2f56eda-d98d-3eaf-e053-3a05fe0a5d97
|
1
|
| Totale |
4.462 |